| Table 3. RIF Pretreatment X RIF Pos Treatment : Cytometric Parametres | |||
| Cytometric Parametres | RIF Pretreatment | RIF Postreatment | P |
| LBR+ | |||
| Endometrial thickness (mm) | 8.8±2(6-13) | 9.64±2.18(6-13) | NS |
| Anormal pathology | 8/16 (50) | 1/16 (6.2) | 0.0031 |
| CFE | |||
| Li/PC | 18.18±8.3(6-32) | 6.91±4.67(2-16) | 0.0045 |
| LT/Li | 48.64±20.4(16-71) | 52.55±14(38-69) | NS |
| LB/Li | 1.64±1.5(0-5) | 1.45±2.16(0-5) | NS |
| NK/Li | 46.73±21.87(22-82) | 36.55±13.9(15-57) | 0.078 |
| CD3+CD4/LTCD3+ | 49.40±9.83(33-64) | 47±7.9(38-65) | NS |
| CD3+CD8/LTCD3+ | 50.64±9.3(36-67) | 52.18±7.75(35-62) | NS |
| CD4/CD8 | 1.04±0.39(0.49-1.77) | 0.94±0.35(0.6-1.8) | NS |
| NK CD56dimCD16bright | 17.56±12.7(5-39) | 19.5±11.9(7-44) | NS |
| NKCD56brightCD16dim | 80.22±14.66(53-95) | 78.5±12.69(55-93) | NS |
| LBR- | |||
| Endometrial thickness (mm) | 8.4±2.3(6-12) | 9.3±1.7(8-13) | NS |
| Anormal pathology | 8/14 (57.1) | 4/14 (28.57) | NS |
| CFE | |||
| Li/PC | 15.57±6.52(4-26) | 6.85±3.89(3-15) | 0.03 |
| LT/Li | 47.85±11.29(36-65) | 41.57±14.79(22-69) | NS |
| LB/Li | 5.42±4.79(0-11) | 2.57±1.39(1-4) | NS |
| NK/Li | 40.42±15.70(20-62) | 55±13.8(30-75) | 0.045 |
| CD3+CD4/LTCD3+ | 42.71±15.27(20-65) | 44±8.48(35-55) | NS |
| CD3+CD8/LTCD3+ | 55.28±14.12(35-80) | 54±6.45(45-63) | NS |
| CD4/CD8 | 0.88±0.53(0.25-1.85) | 0.88±0.26(0.59-1.22) | NS |
| NK CD56dimCD16bright | 12.42±16.0(3-48) | 11.71±4.34(7-20) | NS |
| NKCD56brightCD16dim | 85.28±19.98(41-97) | 86.42±7.04(72-93) | NS |